0
0
Johannesburg, South Africa – March 1, 2025 – South Africa’s National Department of Health has issued a heightened alert following the confirmation of three new monkeypox (mpox) cases in Gauteng Province. This marks the first reported cases of the virus in the country this year, signaling a concerning resurgence since the last recorded case in September 2024.
Foster Mohale, spokesperson for the Department of Health, confirmed that the new cases include a 30-year-old male diagnosed with the Clade I variant of the virus, which is currently circulating in the Democratic Republic of the Congo and Uganda. This patient’s diagnosis followed his recent travel to Uganda. The other two patients, a 27-year-old man and a 30-year-old woman, were identified through contact tracing conducted by the outbreak monitoring team.
The new cases bring South Africa’s cumulative mpox count to 28, including three fatalities, since the outbreak began in May of the previous year. The World Health Organization (WHO) has designated mpox a public health emergency of international concern, emphasizing the need for coordinated global efforts to control its spread and safeguard public health.
South African health authorities are strongly advising individuals who exhibit symptoms of mpox, such as a painful rash, swollen lymph nodes, fever, and fatigue, to seek immediate medical attention.
Understanding Mpox:
Mpox is a contagious disease primarily transmitted through close contact, including skin-to-skin or mouth-to-mouth interactions with infected individuals. Symptoms typically manifest within 1–21 days of exposure and may include fever, muscle aches, headache, and a distinctive rash. While most cases are mild and result in full recovery, severe illness can occur, particularly in individuals with weakened immune systems.
Authorities are closely monitoring the situation and emphasizing the critical importance of preventive measures and early detection to limit the spread of mpox within the community.
Disclaimer: This news article is based on information available at the time of publication. The situation surrounding mpox is dynamic and subject to change. Readers are encouraged to consult official sources, such as the South African National Department of Health and the World Health Organization, for the most up-to-date information and guidance. This article is for informational purposes only and does not constitute medical advice. If you have concerns about your health, please consult a healthcare professional.
